Institutional Ownership
Kairos Pharma Ltd
CUSIP 48301N104COMKAPAQ1 2026
13D / 13G Filings
2
Schedule 13D/13G on record
Beneficial Filers
1
Distinct reporting persons
Largest Stake
10.0%
Max % of class reported
Institutional Holders
9
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
2 filings · latest Aug 14, 2025
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Geode Capital Management, LLC | 111.3K | $62.2K |
| 2 | Sevenbridge Financial Group, LLC | 44.3K | $30.3K |
| 3 | Aptus Capital Advisors, LLC | 44.3K | $24.8K |
| 4 | Two Sigma Investments, LP | 39.5K | $22.1K |
| 5 | State Street Corp | 24.1K | $13.5K |
| 6 | Two Sigma Securities, LLC | 16.2K | $9.1K |
| 7 | Tower Research Capital LLC (Trc) | 4.0K | $2.2K |
| 8 | Hrt Financial LP | 21.6K | $12 |
| 9 | Citigroup Inc | 10 | $6 |